Read the new InFocus article by @Carlhjune and Marco Ruella—
CAR T cell resistance to oncogenic transformation.
bit.ly/3V0sRXR
Penn Medicine

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Cell Press Cell Molecular Therapy Lionel Fonkoua, MD Saad kenderian Sara Elizabeth Siegler Olivia Sirpilla #CARTcells

doi.org/10.1016/j.omto…

We concluded a great #ASGCT2024 meeting in Baltimore, presenting data on #CART cell therapy in Glioblastoma, mechanisms of resistance and how myeloid cells interact with #CART to induce dysfunctions. Best part of the meeting is always to spend time with our lab family

A comprehensive review of how TME interacts with #cart and cancer cells and strategies to overcome inhibition Lionel Fonkoua, MD Olivia Sirpilla R. Leo Sakemura Mayo Clinic Mayo Clinic Comprehensive Cancer Center

Thank you to @kylahingwing for a successful first panel at the #AnnualGenomicsForum2024 with Saad kenderian, Megan Levings, Nathan Michaels and Kevin Song!

#GenomicsForum2024

Unlocking Hope: From #GeneEditing to #ImmuneRevolution

🧪🫀🩺🩸Exploring the frontiers of #GeneEditing and #Immunotherapy at the #AnnualGenomicsForum2024 with today's first panel Saad kenderian, Megan Levings, Nathan Michaels, Kevin Song and @kylahingwing! 🔬🧬

#GenomicsForum2024

What is the role of AI-ECG in #CardioOnc ? Check out this Mayo Clinic #AF risk score study in CLL by Sameer Parikh Zachi Attia Wei Ding Saad kenderian Yucai Wang, MD, PhD Paul Hampel Amber Koehler, PA-C Prashant Kapoor Peter Noseworthy, MD Paul Friedman, MD Joerg Herrmann #JACCCardioOnc

tinyurl.com/ekxw49ny

Congratulations ⁦Paul Hampel⁩ on receiving the best abstract award at the 2024 YIM GCLLSG meeting in Koln! A fantastic conference! #GCLLSG ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦⁦⁦Michael Hallek⁩ ⁦Deborah Stephens⁩

The NPPA Exec team is thrilled to announce the launch of the Mayo Clinic Office of NP PAs - Rochester! 🎉

A culmination of years of hard work & a testimony to Mayo Clinic Rochester’s commitment to recognizing contributions of NPs & PAs across patient care, education, & research!

Registration is open, and keynote speakers have been announced for Mayo Clinic's RegenBio Summit 2024, Dec. 9–11, in Ponte Vedra Beach, Florida. Learn the latest about gene editing, gene therapy, tissue engineering and more.

Get more info and register: mayocl.in/4aZdT9H

.Mayo Clinic Comprehensive Cancer Center director @cherylwillmanmd is part of NCI Disparities’s newly established team of Cancer Equity Leaders. This diverse group of cancer leaders will reimagine and transform the future of cancer #HealthEquity . Learn more: bit.ly/49zzAMv

TET2 regulates early and late transitions in exhausted CD8+ T-cell differentiation and limits CAR T-cell function biorxiv.org/content/10.110…

CAR-MSCs: the New Drivers of Immune System Regulation | Behind the paper Nature Portfolio
Mayo Clinic Olivia Sirpilla Nature Biomedical Engineering

communities.springernature.com/posts/car-mscs…

nature.com/articles/s4155…

#AACR2024 best part is spend time with our lab family and watch them present novel work to advance immunotherapy and #cart for the treatment of cancer. I am fortunate to be working with talented students, fellows and faculty - rising stars in cancer research R. Leo Sakemura

#ISCT Telegraft Hub | summary of CAR engineered MSCs by Dr. Ashley Krull, Ph.D.

Anakinra has been tested clinically to manage CRS & ICANS. How does IL1 signaling directly affect #CART activities? Kun Yun presents her preclinical mechanistic studies today eppro01.ativ.me/appinfo.php?pa… #AACR24 Saad kenderian Mayo Clinic Comprehensive Cancer Center

Ever heard of CAR-MSCs? In the latest edition of the Telegraft, Editor Dr. Ashley Krull, Ph.D. introduces – or re-introduces - the concept of CAR-MSCs and how the latest version of these cells from the lab of Saad kenderian could impact the field.

Read Now: buff.ly/3vSeg6Q

#CAR -T cell therapy is a promising treatment for some blood cancers. Mayo Clinic researchers will jump hurdles to overcome challenges to expanding this #RegenMed immunotherapy to solid tumors in thyroid cancer. Saad kenderian
mayocl.in/49tefUL

Look forward to advancing #CART cell therapy into clinical trials for the treatment of thyroid cancer and other solid tumors Mayo Clinic Mayo Clinic Comprehensive Cancer Center MayoRegMed

So proud to see our phenomenon Mayo Clinic Comprehensive Cancer Center leader, Cheryl Willman, M.D., named one of the Cancer Equity Leaders!!! Congratulations. This is true testament to your amazing leadership, which we already know. You champion Health Equity daily & motivate us to center this in our work!